774-81-2

Usage

Uses

Used in Pharmaceutical Industry:
3-Bromo-4-methoxyphenylacetic acid is used as a key intermediate in the synthesis of various pharmaceuticals for its potential to contribute to the development of new drugs with anti-inflammatory and analgesic properties.
Used in Organic Synthesis:
In the field of organic synthesis, 3-Bromo-4-methoxyphenylacetic acid is utilized as a building block for creating a range of biologically active molecules, highlighting its versatility in chemical reactions.
Used as a Reagent:
3-Bromo-4-methoxyphenylacetic acid is employed as a reagent in the preparation of esters, amides, and other organic compounds, facilitating the synthesis of a diverse array of chemical entities for various applications.

InChI:InChI=1/C9H9BrO3/c1-13-8-3-2-6(4-7(8)10)5-9(11)12/h2-4H,5H2,1H3,(H,11,12)

Upstream product

• 772-59-8 (3-bromo-4-methoxyphenyl)-acetonitrile 
• 19626-36-9 methyl 2-(3-bromo-4-methoxyphenyl)acetate 
• 156-38-7 4-hydroxyphenylacetate 
• 14199-15-6 Methyl 4-hydroxyphenylacetate 
• 38493-59-3 (3-bromo-4-methoxy-phenyl)-methanol 
• 701-94-0 3-bromo-4-methoxybenzyl chloride 
• 34841-06-0 3-bromo-4-methoxybenzylaldehyde 
• 38692-80-7 2-(3-bromo-4-hydroxyphenyl)acetic acid 
• 34918-57-5 methyl 3-bromo-4-hydroxyphenylacetate 
• 23786-14-3 4-methoxy-phenyl acetic acid methyl ester 
• 29973-99-7 4-(3-bromo-4-methoxy-benzylidene)-2-phenyl-4H-oxazol-5-one 
• 77-78-1 dimethyl sulfate 
• 123-11-5 4-methoxy-benzaldehyde 

Downstream Products

• 19626-36-9 methyl 2-(3-bromo-4-methoxyphenyl)acetate 
• 1131-94-8 homoisovanillic acid 
• 702-23-8 2-(4-Methoxyphenyl)ethanol 
• 181115-01-5 1-bromo-5-(2-hydroxyethyl)-2-methoxybenzene 
• 17054-19-2 (3-bromo-4-methoxy-phenyl)-acetic acid-(4-benzyloxy-3-methoxy-phenethylamide) 
• 212688-01-2 4-(3-Bromo-4-methoxy-phenyl)-3-oxo-2-(triphenyl-λ⁵-phosphanylidene)-butyronitrile 
• 143399-01-3 (3-bromo-4-methoxy-phenyl)-acetyl chloride 
• 72527-24-3 1-(3-bromo-4-methoxy-benzyl)-6,7-dimethoxy-3,4-dihydro-isoquinoline 
• 109400-46-6 2-(3-Bromo-4-methoxyphenyl)-N-<2-(3,4-dimethoxyphenyl)-ethyl>-acetamide 
• 117584-89-1 2-(3-Bromo-4-methoxyphenyl)-N-<2-(3-methoxyphenyl)-ethyl>-acetamide 
• 117565-98-7 1-(3-Bromo-4-methoxybenzyl)-1,2,3,4-tetrahydro-6-methoxyisoquinoline 
• 117566-02-6 1-(3-Bromo-4-methoxybenzyl)-1,2,3,4-tetrahydro-6,7-dimethoxyisoquinoline 
• 38692-80-7 2-(3-bromo-4-hydroxyphenyl)acetic acid 
• 869497-70-1 (E)-2-(3'-bromo-4'-methoxyphenyl)-3-(3'',4'',5''-trimethoxyphenyl)acrylic acid 

Relevant academic research and scientific papers

Novel dihydroquinolizinones for the treatment and prophylaxis of hepatitis B virus infection

The invention provides novel compounds having the general formula: wherein R1, R2, R3, R4, R5 and R6 are as described herein, compositions including the compounds and methods of using the compounds.

NOVEL DIHYDROQUINOLIZINONES FOR THE TREATMENT AND PROPHYLAXIS OF HEPATITIS B VIRUS INFECTION

The invention provides novel compounds having the general formula (I) wherein R1, R2 R3, R4, R5 and R6 are as described herein, compositions including the compounds and methods of using the compounds in the treatment of the hepatitis B virus.

PHENYL-ALKYL PIPERAZINES HAVING TNF-MODULATING ACTIVITY, PREPARATION METHOD, AND THERAPEUTIC USE THEREOF

The present invention relates to phenyl-alkyl piperazines of formula (I): in which A, R1, R2 and R3 are as defined herein, having TNF-modulating activity. The invention also relates to the preparation thereof, pharmaceutical compositions thereof, and to t

2- [5- (5-carbamimidoyl-1H-heteroaryl)-6-hydroxybiphenyl-3-yl]-succinic acid derivatives as factor viia inhibitors

The present invention relates to novel inhibitors of Factors VIIa, IXa, Xa, XIa, in particular Factor VIIa, pharmaceutical compositions comprising these inhibitors, and methods for using these inhibitors for treating or preventing thromboembolic disorders. Processes for preparing these inhibitors are also disclosed.

Syntheses of the marine metabolites verongamine, hemibastadin-2, and aerothionin using the cyano ylide coupling methodology

Syntheses of the marine metabolites verongamine, hemibastadin-2, and aerothionin have been accomplished by a methodology involving the conversion of a carboxylic acid to an acyl cyano phosphorane which may be oxidized to an α,β-diketo nitrile. This strong